Biologics and Biosimilars Congress 2017 will feature new extended panel discussions with senior executives from prominent organisations. Drawing on their experience and insights these leaders will discuss the challenges, opportunities and future direction of a range promising research fields. The panels will cover themes such as 'advancing immunotherapy', 'ADCs: Design and optimisation' and 'Biosimilars: Communication and Awareness'.
In addition round table discussions will offer attendees the opportunity to discuss important topics in the field of Biosimilars. Focusing on regulation, public perception and development issues; the conversation will be facilitated by leaders in the respective fields and enable further exploration of themes raised in the conference agenda.
As well as providing ample opportunity for you to ask questions of the panellists, there are over 6 hours of networking time allocated throughout the congress, including the drinks reception at the end of day one. This will help you make the most of the opportunity to talk further with the 60 plus speaker faculty as well as the other delegates and meeting's sponsors and exhibitors.
Attracting industry, regulatory and academic experts working in all areas of protein and antibody research, the 3rd Biologics and Biosimilars Congress will offer an opportunity for you to take home cutting edge strategies, case study examples, regulatory guidelines to allow you to keep abreast of this dynamic field. This will be achieved through a vibrant exhibition room full of technology providers showcasing their solutions, networking breaks, expert-led case study presentations and incisive panel discussions, divided over four tracks.
- Antibody Based Therapeutics
- Protein Biotherapeutics
- Biosimilars
In addition round table discussions will offer attendees the opportunity to discuss important topics in the field of Biosimilars. Focusing on regulation, public perception and development issues; the conversation will be facilitated by leaders in the respective fields and enable further exploration of themes raised in the conference agenda.
As well as providing ample opportunity for you to ask questions of the panellists, there are over 6 hours of networking time allocated throughout the congress, including the drinks reception at the end of day one. This will help you make the most of the opportunity to talk further with the 60 plus speaker faculty as well as the other delegates and meeting's sponsors and exhibitors.
Attracting industry, regulatory and academic experts working in all areas of protein and antibody research, the 3rd Biologics and Biosimilars Congress will offer an opportunity for you to take home cutting edge strategies, case study examples, regulatory guidelines to allow you to keep abreast of this dynamic field. This will be achieved through a vibrant exhibition room full of technology providers showcasing their solutions, networking breaks, expert-led case study presentations and incisive panel discussions, divided over four tracks.
- Antibody Based Therapeutics
- Protein Biotherapeutics
- Biosimilars
